专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

标题翻译：芳香酶抑制剂

公开(公告)号：WO2011023989A1

公开(公告)日：2011-03-03

申请号：PCT/GB2010/051391

申请日：2010-08-23

申请人： STERIX LIMITED , WOO, Lok Wai Lawrence , BUBERT, Christian , WOOD, Paul Michael , PUTEY, Aurélien , PUROHIT, Atul , POTTER, Barry Victor Lloyd

发明人： WOO, Lok Wai Lawrence , BUBERT, Christian , WOOD, Paul Michael , PUTEY, Aurélien , PUROHIT, Atul , POTTER, Barry Victor Lloyd

IPC分类号： C07D249/08 , C07D401/12 , C07D403/12 , C07D405/12 , C07D409/12 , A61K319/4196 , A61K31/496 , A61K31/5355 , A61K31/55 , A61P35/00

CPC分类号： C07D249/08 , C07D401/12 , C07D403/12 , C07D405/12 , C07D409/12

摘要： There is provided a compound of formula (I) wherein Z is selected from N and CR 22 , wherein R 22 is H or a bond with D, wherein D is selected from a bond, C=O, and linear or branched hydrocarbon groups having a carbon chain of from 1 to 6 carbon atoms, wherein the carbon chain optionally contains an oxy group (=0), an ether (-0-) or thioether (-S-) link, wherein R 1 is selected from :triazolyl, imidazolyl, pyrimidinyl radical wherein each of R 2 to R 6 is independently selected from -H, NO 2 , halo, -CN, -N[(C=O) 0-1 R 12 ][(C=O) 0-1 R 13 ] and -(CH 2 ) 0-1 R 14 , or two adjacent groups of R2 to R6, together with the carbon atoms to which they are attached, form a ring, wherein at least one of R 2 to R 6 is -CN, wherein (i) at least one of R 2 to R 6 is -(CH 2 ) 0-1 R 14 , or (ii) at least one of R 2 to R 6 is -N[(C=O) 0-1 , R 12 ][(C=O) 0-1 R 13 ], or (iii) at least two adjacent groups of R 2 to R 6 together with the carbon atoms to which they are attached, form a ring, or (iv) at least one of R 2 to R 6 is -(CH 2 ) 0-1 O-R' 14 , wherein R 12 and R 13 are independently selected from H, linear or branched hydrocarbon groups having a carbon chain of from 1 to 10 carbon atoms, or together with the atoms to which they are attached, may form a mono or bicyclic ring having from 5 to14 ring members wherein R 14 is selected from: aliphatic ring systems; unsubstituted or substituted monocyclic aliphatic heterocycles; unsubstituted or substituted heteroaryl radical, and unsubstituted or substituted phenyl group; the group of formula (a) wherein t is 1 or 2, wherein R' 14 is a unsubstituted or substituted phenyl group, wherein each of R 7 to R 11 is independently selected from -H, NO 2 , halo, -O-(C 1 -C 6 )haloalkyl, (C 1 -C 6 )haloalkyl, (C 1 -C 6 )alkyl, -CN, -OH, -OPh, -OBn, -Ph, -OSO 2 NR 15 R 16 , -SO 2 R 26 , -SO 2 NR 27 NR 28 , -O-(C 1 C 6 )alkyl, -(C=O) 0-1 NR 29 R 30 and -CO(O) 0-1 R 31 ; wherein R 15 and R 16 are independently selected from H, alkyl, cycloalkyl, alkenyl, acyl and aryl, or combinations thereof, or together represent alkylene, wherein the or each alkyl or cycloalkyl or alkenyi optionally contain one or more hetero atoms or groups wherein each of R 26 to R 31 is independently selected from H, alkyl, cycloalkyl, alkenyl, acyl and aryl, or combinations thereof, or together represent alkylene, wherein the or each alkyi or cycloalky! or alkenyl optionally contain one or more hetero atoms or groups, or any pharmaceutically acceptable salts thereof.

摘要翻译：提供式（I）化合物，其中Z选自N和CR 22，其中R 22是H或与D的键，其中D选自键，C = O和具有碳的直链或支链烃基具有1至6个碳原子的链，其中所述碳链任选地含有氧基（= O），醚（-O-）或硫醚（-S-）连接，其中R 1选自：三唑基，咪唑基，嘧啶基其中R2至R6各自独立地选自-H，NO2，卤素，-CN，-N [（C = O）0-1R12] [（C = O）0-1R13]和 - （CH2） 1R14或R 2至R 6的两个相邻基团与它们连接的碳原子一起形成环，其中R 2至R 6中的至少一个为-CN，其中（i）R 2至R 6中的至少一个为 - （CH 2）0-1R 14，或（ii）R 2至R 6中的至少一个为-N [（C = O）0-1，R 12] [（C = O）0-1R 13]，或（iii） R 2至R 6的至少两个相邻基团与它们所连接的碳原子一起形成环，或（iv）R 2至R 6中的至少一个为 - （CH 2）0-1R-14， ein R 12和R 13独立地选自H，具有1至10个碳原子的碳链的直链或支链烃基，或与它们所连接的原子一起可以形成具有5至14个环的单环或双环其中R 14选自：脂族环系; 未取代或取代的单环脂族杂环; 未取代或取代的杂芳基，以及未取代或取代的苯基; 式（a）的基团，其中t为1或2，其中R'14为未取代或取代的苯基，其中R7至R11各自独立地选自-H，NO2，卤素，-O-（C1-C6 ）卤代烷基，（C1-C6）卤代烷基，（C1-C6）烷基，-CN，-OH，-OPh，-OBn，-Ph，-OSO2NR15R16，-SO2R26，-SO2NR27NR28，-O-（C1C6）烷基，（C = O）0-1NR29R30和-CO（O）0-1R31; 其中R 15和R 16独立地选自H，烷基，环烷基，烯基，酰基和芳基或其组合，或一起表示亚烷基，其中烷基或环烷基或烯基任选地含有一个或多个杂原子或基团， R 26至R 31独立地选自H，烷基，环烷基，烯基，酰基和芳基，或其组合，或一起表示亚烷基，其中每个烷基或环烷基或烯基任选地含有一个或多个杂原子或基团，或其任何药学上可接受的盐。

IPRDB

热门服务

关于我们

友情链接

联系方式